10Followers on Owler

Taxon Biosciences

Read more
Glenn Nedwin's photo - President & CEO of Taxon Biosciences

President & CEO

Glenn Nedwin

CEO Approval Rating

52/100

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
1-25
Agree?
Funding
$0
Industry

Update Industry
Sector

Update Industry

Taxon Biosciences Competitors and Alternatives

1
3
5
7
9
2
4
6
8
10
See more competitor data

Taxon Biosciences News

Taxon Biosciences Press Releases

Taxon Biosciences Headquarters

3150 Paradise Dr Building 30

Tiburon, California94920

415-435-5116

Driving Directions »

Taxon Biosciences Summary

ABOUT

Overview

Taxon Biosciences engages in the development of transformational microbial products for the agriculture, life sciences, oil and gas industries. Taxon Biosciences was founded in 2000. Taxon Biosciences' headquarters is located in Tiburon, California, U...

CEO

Taxon Biosciences's President & CEO, Glenn Nedwin, currently has an approval rating of 52%. Taxon Biosciences's primary competitors are Second Genome, Seres Therapeutics & MicroBiome Therapeutics, LLC.

Website

taxon.com

Acquisitions

There have been no acquisitions found related to Taxon Biosciences

Funding

Funding data cannot be found related to Taxon Biosciences

Investments

Recent investment data cannot be found related to Taxon Biosciences

Frequently Asked Questions about Taxon Biosciences

  1. When was Taxon Biosciences founded?

    Taxon Biosciences was founded in 2000
  2. Who is Taxon Biosciences's CEO?

    Taxon Biosciences's CEO is Glenn Nedwin
  3. How much revenue does Taxon Biosciences generate?

    Taxon Biosciences generates $5M in revenue
  4. How much funding does Taxon Biosciences have?

    Taxon Biosciences has historically raised $0 in funding
  1. Where is Taxon Biosciences's headquarters?

    Taxon Biosciences's headquarters is in Tiburon California, USA
  2. How many employees does Taxon Biosciences have?

    Taxon Biosciences has 20 employees
  3. Who are Taxon Biosciences's competitors?

    Taxon Biosciences's top competitors are Second Genome, Seres Therapeutics, MicroBiome Therapeutics, LLC

Trending Companies